Published Technical Disclosure Archive

Advanced Oral Pain Relief System

Publication ID: 24-11857676_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Advanced Oral Pain Relief System,” Published Technical Disclosure No. 24-11857676_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857676_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,676.

Summary of the Inventive Concept

A next-generation oral pain relief system leveraging nanotechnology, artificial intelligence, and micro-robots to provide rapid, long-lasting, and personalized pain relief

Background and Problem Solved

The original patent addressed oral pain relief through dissolvable compositions, but limitations existed in terms of effectiveness, customization, and detection of oral pain. The new inventive concept overcomes these limitations by integrating cutting-edge technologies to provide a more comprehensive and proactive solution

Detailed Description of the Inventive Concept

The advanced oral pain relief system consists of a wearable, intra-oral device that detects oral pain and dispenses a customized, dissolvable composition comprising a nanotechnology-enhanced carrier and at least one active ingredient. The system utilizes artificial intelligence to analyze a subject's medical history and oral health data to predict the likelihood of oral pain and preventively administer the customized composition. Additionally, a network of micro-robots can be deployed to navigate the oral cavity and detect areas of oral pain, with the central controller dispensing the customized composition in response

Novelty and Inventive Step

The new claims introduce novel elements such as nanotechnology-enhanced carriers, wearable intra-oral devices, artificial intelligence-driven predictive analytics, and micro-robots, which are non-obvious and significantly improve upon the original patent's composition-based approach

Alternative Embodiments and Variations

Alternative embodiments may include variations in the composition's active ingredients, different types of wearable devices, or alternative methods of detecting oral pain. The system could also be adapted for use in veterinary care or other applications beyond human oral health

Potential Commercial Applications and Market

The advanced oral pain relief system has significant commercial potential in the oral healthcare industry, with potential applications in dental clinics, hospitals, and consumer products. The system's ability to provide rapid, long-lasting, and personalized pain relief could revolutionize the treatment of oral pain, addressing a significant unmet need in the market

CPC Classifications

SectionClassGroup
A A61 A61K9/006
A A61 A61K31/045
A A61 A61K31/047
A A61 A61K31/085
A A61 A61K36/53
A A61 A61K36/534
A A61 A61K36/9064
A A61 A61K47/10
A A61 A61K47/26
A A61 A61P23/02

Field of Art

Pharmaceutical compositions for oral pain management, with expertise in drug delivery systems, natural compound formulations, and medical device technologies spanning pharmacology, nanotechnology, and biomedical engineering

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences or biomedical engineering, familiar with oral drug delivery mechanisms, natural compound interactions, and emerging medical technologies like nanotechnology and AI-driven medical interventions

Obviousness Rationale

A PHOSITA would recognize that the published technical disclosure represents predictable technological extensions of the source patent's oral pain relief composition, utilizing known techniques in nanotechnology, artificial intelligence, and drug delivery to enhance the original formulation's effectiveness and application methodology.

Obvious Combinations & Variations

Source Patent Element
Dissolvable oral pain relief composition with specific active ingredients
PTD Variation
Nanotechnology-enhanced carrier targeting specific pain receptors
Obviousness Reasoning
Nanotechnology-based drug delivery is a known technique for improving compound absorption and targeted delivery, representing a predictable optimization of the original composition's effectiveness
Source Patent Element
Fixed composition of guaiacol, eugenol, glycerin, menthol, and other oils
PTD Variation
Addition of synthetic analgesic compound targeting TRPV1 receptors
Obviousness Reasoning
Expanding active ingredient profiles with complementary analgesic compounds is a standard pharmaceutical development approach for enhancing pain management efficacy
Source Patent Element
Static oral pain relief composition
PTD Variation
AI-driven predictive pain management system with wearable intra-oral device
Obviousness Reasoning
Integrating sensor technologies and artificial intelligence for personalized medical interventions is a foreseeable technological progression in medical device design
Source Patent Element
Topical oral pain relief method
PTD Variation
Micro-robot network for detecting and responding to oral pain locations
Obviousness Reasoning
Advanced diagnostic and delivery technologies represent incremental improvements using known robotics and sensing principles applied to medical contexts
Source Patent Element
Composition limited to specific natural oil combinations
PTD Variation
Customizable composition adaptable across human and veterinary applications
Obviousness Reasoning
Expanding medical technologies across species and use cases is a standard approach in pharmaceutical and medical device development
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857676, a person having ordinary skill in the art would find the variations disclosed in this published technical disclosure to be obvious extensions of the prior art, representing predictable technological improvements using known techniques in nanotechnology, artificial intelligence, and targeted drug delivery systems. The disclosed innovations constitute obvious combinations that would be apparent to a skilled practitioner in pharmaceutical composition and medical device technologies.

Original Patent Information

Patent NumberUS 11,857,676
TitleCompositions for oral pain relief
Assignee(s)ORCA PRODUCTS, LLC